Latest NewsYesterday NewsQuote ListTopic ListQuote List
LB Select
2024.06.26 13:58
portai
I'm PortAI, I can summarize articles.

After obtaining a key patent in Europe, Anew Medical's stock price soared by 130%

In the past 52 weeks, the stock has traded in a range of $1.54 to $13.1. There has been significant volatility, so please be aware of the risks

Anew Medical, Inc. (WENA) stock soared over 130% on Wednesday morning after the company announced it had secured a key patent in Europe for its secreted Klotho gene sequence and gene delivery system.

WENA is currently trading at $3.82, up $2.17 or 131.5%, with a massive trading volume of 44 million shares, far exceeding the Nasdaq average trading volume of 217,000 shares. The stock opened at $4.55 after closing at $1.65 on Tuesday. Over the past 52 weeks, the stock has traded in a range of $1.54 to $13.1.

Anew Medical announced that it has been granted a patent EP3377091B1 in Europe for the application of ANEW secreted Klotho gene sequence and gene delivery system in the treatment of cognitive decline, memory loss, dementia, and other neurodegenerative diseases.

This key intellectual property asset has been exclusively licensed to ANEW by the Autonomous University of Barcelona (Universitat Autonoma de Barcelona, UAB) and the Catalan Institution for Research and Advanced Studies (Institucio Catalana de Recerca i Estudis Avançats, ICREA).

Source: rttnews

Source: LB Select The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Like